The Valley Desk

Clinical trial reportSleep & breathing = Schlaf & AtmungPublished

Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Sleep & breathing = Schlaf & Atmung
Published
Subject terms
Humans; Sleep Apnea, Obstructive; Hypertension; Spironolactone; Adrenergic Uptake Inhibitors; Polysomnography; Drug Therapy, Combination; Cross-Over Studies; Blood Pressure; Adult; Aged; Middle Aged
PubMed ID
39305436
Added to directory
Source checked

Report a correction or request removal